Where does Valorisation HSJ, Limited Partnership rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Valorisation HSJ, Limited Partnership ranks #27,750 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Valorisation HSJ, Limited Partnership hold?

Valorisation HSJ, Limited Partnership holds 10 US utility patents granted between 2015 and 2025, spanning 18 technology areas.

What is Valorisation HSJ, Limited Partnership's Innovation Score?

Valorisation HSJ, Limited Partnership has an Innovation Score of 40.3 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Valorisation HSJ, Limited Partnership's patent grant rate increasing or decreasing?

Valorisation HSJ, Limited Partnership's recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Valorisation HSJ, Limited Partnership's patents?

Valorisation HSJ, Limited Partnership's patents average 17.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Valorisation HSJ, Limited Partnership patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Valorisation HSJ, Limited Partnership

Q: What technology areas does Valorisation HSJ, Limited Partnership focus on?

Valorisation HSJ, Limited Partnership's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 5 patents. Grants appear in 18 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Valorisation ranks #27,750 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 18 technology areas.

#27,750
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.3/100): 17.3
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R27750 · Foreign Corporation #27,750 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #27,750/49,997
PHOTO-FINISH Uwiz Technology
CPC-FOCUS A61P · 18 areas
INNOV-PAR 40.3/100
CLAIMS-RICH 17.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Uwiz Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Valorisation HSJ… · this assignee

40
3D Lighting… · lowest

7

What this shows Valorisation's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Valorisation's grants concentrate

Valorisation HSJ, Limited Partnership is a focused PatentsView assignee: 18 CPC subclasses with 50% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (2 grants) versus a trough of 1 in 2015. By volume, Valorisation sits between Uwiz Technology Co., Ltd. and Verisilicon Microelectronics (NANJING) Co., Ltd..

Valorisation's three-year grant acceleration

Valorisation HSJ, Limited Partnership shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Uwiz Technology

10
Vallourec Drillin…

10
Vallourec Tubes F…

10
Valneva

10
Veda Data Solutio…

10
Velo Enterprise

10
Venus Aerospace

10
Verisilicon Micro…

10
Valorisation HSJ… ◀

10

What this shows Valorisation holds 10 patents at rank #27,736, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Valorisation

By rank, the assignees closest to #27,736 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Valorisation's primary technology class.

Valorisation's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Valorisation HSJ, Limited Partnership patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	10.0%
2016	1	10.0%
2017	2	20.0%
2018	1	10.0%
2019	1	10.0%
2021	1	10.0%
2022	1	10.0%
2023	1	10.0%
2025partial year	1	10.0%

Which technologies does Valorisation HSJ, Limited Partnership patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

C07K - Peptides 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

C10M - Lubricating Compositions ; USE OF Chemical Substances Either Alone OR AS Lubricating Ingredients IN A Lubricating Composition 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 2

C08B - POLYSACCHARIDES; Derivatives Thereof 2

C08L - Compositions OF Macromolecular Compounds 2

C10N - Indexing Scheme Associated With Subclass C10m Relating TO Lubricating Compositions 2

A61B - DIAGNOSIS; SURGERY; Identification 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C07D - Heterocyclic Compounds 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

Top 15 of 18 technology areas

Where it ranks

Overall rank by patents

#27,750

of 49,997 tracked assignees

Innovation Score

40.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Valorisation HSJ, Limited Partnership's patent record in context - here's where to go next.

Valorisation HSJ, Limited Partnership's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 50% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #27,750 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Valorisation HSJ, Limited Partnership against Uwiz Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.